Vista, Calif.-based DJO Global reported its financial results for the second quarter, ending July 1.
Here are nine key points:
1. DJO's net sales increased by 4.6 percent to $292.9 million, compared to $279.9 million in the second quarter of 2015.
2. The company's adjusted EBITDA hit $63.6 million, a 3.7 percent increase from the same period the year prior.
3. DJO saw a net loss of $23.3 million during the second quarter, compared to a net loss of $78 million in the same period the year prior.
4. DJO's bracing and vascular segment net sales hit $131.8 million, down 3.3 percent from the second quarter of 2015. The company believes delivery complications resulted in this drop.
5. The recovery sciences segment net sales reached $38.4 million, a 4.1 percent decrease compared to the same period a year prior.
6. The company's international segment net sales totaled $80.1 million, a 6 percent increase from the second quarter of 2015. DJO's shoulder, knee and hip product lines spurred this growth.
7. DJO's cash balances equal $41.7 million and its available liquidity is $67.5 million under the $150 million revolving credit facility.
8. DJO anticipates growth in its top line and constant currency revenue growth rates of 6 percent.
9. Looking ahead, the company expects adjusted EBITDA growth rate between 8 percent and 10 percent for 2016.